Wrapping up Q2 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Bio-Techne faces significant macro and policy headwinds, including reduced academic research funding, China risks, and U.S. healthcare reforms, limiting near-term growth. Despite a solid business ...

Fintel reports that on March 18, 2025, Evercore ISI Group initiated coverage of Bio-Techne (NasdaqGS:TECH) with a Outperform recommendation. As of March 4, 2025, the average one-year price target for ...